Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cathay Financial Holdings is the largest financial services group in Taiwan, offering a wide array of services including life insurance, banking, and asset management. The company maintains a significant presence in the healthcare sector through its ownership of Cathay General Hospital and its extensive health insurance operations. While it is a major institutional investor in the biotechnology and life sciences industries through its venture capital arm, Cathay Venture, the company does not engage in internal drug discovery or clinical development. Headquartered in Taipei, it operates a vast network across the Asia-Pacific region, including China and Southeast Asia. The company is publicly traded on the Taiwan Stock Exchange under the ticker 2882 and is a key component of regional financial indices. It is recognized for its digital transformation and ESG initiatives within the financial industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cathay Financial Holdings.